Plasma IL-5 levels are associated with antibodies to oxidized LDL and subclinical atherosclerosis in humans

被引：0
|
作者：
Sampi, M.
Ukkola, O.
Paivansalo, M.
Ruskoaho, H.
Kesaniemi, Y. A.
Horkko, S.
机构：
[1] Oulu Univ Hosp, Dept Internal Med, Oulu, Finland
[2] Oulu Univ Hosp, Dept Radiol, Oulu, Finland
[3] Oulu Univ Hosp, Dept Pharmacol & Toxicol, Oulu, Finland
[4] Univ Oulu, Bioctr Oulu, Oulu, Finland
[5] Oulu Univ Hosp, Clin Res Ctr, Oulu, Finland
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2007年 / 8卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(07)71529-5
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：144 / 145
页数：2
相关论文
共 50 条
  • [1] Plasma IL-5 concentration and subclinical carotid atherosclerosis
    Silveira, Angela
    McLeod, Olga
    Strawbridge, Rona J.
    Gertow, Karl
    Sennblad, Bengt
    Baldassarre, Damiano
    Veglia, Fabrizio
    Deleskog, Anna
    Persson, Jonas
    Leander, Karin
    Gigante, Bruna
    Kauhanen, Jussi
    Rauramaa, Rainer
    Smit, Andries J.
    Mannarino, Elmo
    Giral, Philippe
    Gustafsson, Sven
    Soderberg, Stefan
    Ohrvik, John
    Humphries, Steve E.
    Tremoli, Elena
    de Faire, Ulf
    Hamsten, Anders
    ATHEROSCLEROSIS, 2015, 239 (01) : 125 - 130
  • [2] ANTIBODIES TO OXIDIZED LDL IN ATHEROSCLEROSIS
    不详
    LANCET, 1992, 339 (8798): : 899 - 900
  • [3] IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis
    Binder, CJ
    Hartvigsen, K
    Chang, MK
    Miller, M
    Broide, D
    Palinski, W
    Curtiss, LK
    Corr, M
    Witztum, JL
    JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (03): : 427 - 437
  • [4] Plasma Interleukin-5 Levels Are Related to Antibodies Binding to Oxidized Low-Density Lipoprotein and to Decreased Subclinical Atherosclerosis
    Sampi, Maritta
    Ukkola, Olavi
    Paivansalo, Markku
    Kesaniemi, Y. Antero
    Binder, Christoph J.
    Horkko, Sohvi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (17) : 1370 - 1378
  • [5] Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR study)
    Hulthe, J
    Fagerberg, B
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (07) : 1162 - 1167
  • [6] ATHEROSCLEROTIC AND METABOLIC REPERCUSSIONS OF INCREASED PLASMA LEVELS OF OXIDIZED LDL AND ANTIBODIES AGAINST OXIDIZED LDL IN ASYMPTOMATIC ADULTS
    Santiago, F. D.
    Moriel, P.
    Correa, R. O.
    Nakamura, R. T.
    Gidlund, M.
    Schreiber, R.
    Barros-Mazon, S.
    de Faria, E. Cotta
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 91 - 91
  • [7] Oxidized LDL antibodies in treatment and risk assessment of atherosclerosis and associated cardiovascular disease
    Nilsson, Jan
    Fredrikson, Gunilla Nordin
    Schiopu, Alexandru
    Shah, Prediman K.
    Jansson, Bo
    Carlsson, Roland
    CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (10) : 1021 - 1030
  • [8] Weight loss is associated with a decrease in plasma levels of oxidized LDL
    Mertens, A
    Muls, E
    Holvoet, P
    INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S124 - S124
  • [9] Impact of plasma oxidized LDL removal on atherosclerosis
    Ishigaki, Yasushi
    Katagiri, Hideki
    Gao, Junhong
    Oka, Yoshitomo
    DIABETES, 2008, 57 : A200 - A200
  • [10] Carbamylated LDL but not oxidized LDL is associated with atherosclerosis in uremic patients
    Basnakian, Alexei G.
    Apostolov, Eugene O.
    Ok, Ercan
    Yin, Xiaoyan
    Altunel, Ekrem
    Shah, Sudhir V.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 434 - 434
12345